PL364983A1 - Kompozycja szczepionkowa i sposób jej stosowania - Google Patents

Kompozycja szczepionkowa i sposób jej stosowania

Info

Publication number
PL364983A1
PL364983A1 PL00364983A PL36498300A PL364983A1 PL 364983 A1 PL364983 A1 PL 364983A1 PL 00364983 A PL00364983 A PL 00364983A PL 36498300 A PL36498300 A PL 36498300A PL 364983 A1 PL364983 A1 PL 364983A1
Authority
PL
Poland
Prior art keywords
same
vaccine composition
vaccine
composition
Prior art date
Application number
PL00364983A
Other languages
English (en)
Inventor
Gilad Gallili
Norbert Frydman
Original Assignee
Teva Pharmaceutical Industries, Ltd.
Teva Pharmaceuticals Usa, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals Usa, Inc. filed Critical Teva Pharmaceutical Industries, Ltd.
Publication of PL364983A1 publication Critical patent/PL364983A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
PL00364983A 1999-08-24 2000-08-21 Kompozycja szczepionkowa i sposób jej stosowania PL364983A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15051499P 1999-08-24 1999-08-24

Publications (1)

Publication Number Publication Date
PL364983A1 true PL364983A1 (pl) 2004-12-27

Family

ID=22534899

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00364983A PL364983A1 (pl) 1999-08-24 2000-08-21 Kompozycja szczepionkowa i sposób jej stosowania

Country Status (21)

Country Link
US (1) US6541001B1 (pl)
EP (1) EP1212045B1 (pl)
JP (1) JP5209160B2 (pl)
CN (1) CN100406004C (pl)
AU (1) AU779403B2 (pl)
BR (1) BRPI0014142B8 (pl)
CA (1) CA2382652A1 (pl)
CY (1) CY1118521T1 (pl)
DK (1) DK1212045T3 (pl)
ES (1) ES2605109T3 (pl)
HK (1) HK1047696A1 (pl)
HU (1) HUP0202537A3 (pl)
IL (2) IL148247A0 (pl)
LT (1) LT1212045T (pl)
MX (1) MXPA02001891A (pl)
PL (1) PL364983A1 (pl)
PT (1) PT1212045T (pl)
RU (1) RU2277905C2 (pl)
TR (1) TR200200477T2 (pl)
WO (1) WO2001013896A1 (pl)
ZA (1) ZA200201816B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
AU2002951692A0 (en) * 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
EP1583506B1 (en) * 2003-01-07 2012-03-07 Yeda Research And Development Co., Ltd. Eye-drop vaccine containing copolymer 1 for therapeutic immunization
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
MXPA05009079A (es) * 2003-02-28 2006-05-19 Alk Abello As Forma de dosificacion que tiene una matriz de sacarido.
US7858607B2 (en) * 2003-03-14 2010-12-28 Mamchur Stephen A System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
EP1697035B1 (en) * 2003-12-22 2017-11-15 Warren H. Finlay Powder formation by atmospheric spray-freeze drying
US20050175630A1 (en) * 2003-12-23 2005-08-11 Eyal Raz Immunogenic compositions and methods of use thereof
JP2006143594A (ja) * 2004-11-16 2006-06-08 Shionogi & Co Ltd 注射錠
US8097245B2 (en) 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP1981547B1 (en) * 2005-12-28 2015-09-30 Alza Corporation Stable therapeutic formulations
DE102006054260A1 (de) * 2006-02-28 2007-09-27 Lohmann Animal Health Gmbh & Co. Kg Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
JP4935761B2 (ja) * 2008-06-02 2012-05-23 株式会社微生物化学研究所 家禽大腸菌症ワクチン
EP2435554B1 (en) 2009-05-26 2017-07-26 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
EP2529004B1 (en) 2010-01-28 2017-06-07 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
EA201390812A1 (ru) 2010-12-02 2013-11-29 Онколитикс Байотек Инк. Лиофилизированные вирусные составы
EA201390810A1 (ru) 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
WO2013025274A1 (en) * 2011-08-12 2013-02-21 Merial Limited Vacuum -assisted preservation of biological products, in particular of vaccines
CA2866889C (en) * 2012-03-23 2021-08-31 Advanced Bionutrition Corporation Stabilizing composition for biological materials
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物
ES2870623T3 (es) 2014-12-22 2021-10-27 The Univ Of Georgia Research Foundation Inc Sistema para vacunación de aves
BR112018001784B1 (pt) 2015-07-29 2022-05-10 Advanced Bionutrition Corp Composições probióticas secas estáveis para usos dietéticos especiais, seu método de preparação e método de preparação de uma fórmula para bebês

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929377A (en) 1961-02-09 1963-06-19 Carl Peter Varnet Foot and mouth disease implantation preparations
US3317393A (en) 1964-06-08 1967-05-02 Robert M Chanock Immunization by selective infection of the intestinal tract with an encapsulated live virus
US3458621A (en) * 1966-08-31 1969-07-29 American Home Prod Tablet dosage-form for the immunization of the intestinal tract with live virus preparations
US3603030A (en) 1969-08-29 1971-09-07 Remco Ind Inc Jumping toy
FR2082760A5 (en) 1970-03-26 1971-12-10 France Etat Aerosol immunisation appts - for freeze-dried vaccines
DD106660A1 (pl) 1972-04-10 1974-06-20
US3893280A (en) 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
DE2237783A1 (de) 1972-08-01 1974-02-14 Bayern Freistaat Impfstoffzubereitung zur oralen pocken-impfung
DD117250A1 (pl) 1974-11-20 1976-01-05
BE853923A (fr) 1977-04-25 1977-10-25 Rit Rech Ind Therapeut Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4251509A (en) 1980-01-31 1981-02-17 Wisconsin Alumni Research Foundation Dry particulate vaccine for oral administration
US4458630A (en) 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
JPS63264518A (ja) * 1987-04-21 1988-11-01 Wakamoto Pharmaceut Co Ltd 発泡性錠剤の製法
IE61575B1 (en) 1987-05-04 1994-11-16 Merck & Co Inc A stable lyophilized live herpes virus vaccine
US5710014A (en) 1988-02-11 1998-01-20 The United States Of America As Represented By The Department Of Health And Human Services Cloned cDNA for human procathepsin l.
US5472710A (en) 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
IL89899A (en) 1988-05-16 1992-12-01 Reynolds Tobacco Co R Smoking article with improved means for delivering flavorants
US5350741A (en) 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
AU646232B2 (en) 1989-10-02 1994-02-17 Cima Labs, Inc. Effervescent dosage form and method of administering same
ES2102368T3 (es) 1989-10-02 1997-08-01 Univ Arkansas Conjugado de vacuna para el tratamiento de las enfermedades de las aves.
WO1991004750A1 (en) * 1989-10-02 1991-04-18 Embrex, Inc. Method of treatment
DD289201A5 (de) 1989-11-28 1991-04-25 Fi Fuer Lungenkrankheiten Und Tuberkulose,De Verfahren zur herstellung einer immunmodulierenden vakzine gegen viren
DD289200A5 (de) 1989-11-28 1991-04-25 Forsch Lungenkrankheiten Und T Verfahren zur herstellung einer kombinationsvakzine mit intensivierter wirkung
US5091188A (en) 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
FR2662942B1 (fr) * 1990-06-06 1992-09-18 Neway Tsehay Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
US5178882A (en) 1990-06-22 1993-01-12 The Regents Of The University Of California Viral decoy vaccine
NZ286242A (en) 1991-03-26 1997-11-24 Csl Ltd Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient
US5206219A (en) 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
ES2199944T3 (es) * 1992-07-06 2004-03-01 Avant Immunotherapeutics Inc. (Titular Al 50%) Procedimiento para la elaboracion de una cepa mutante geneticamente estable de vibrio cholerae.
WO1994017813A1 (en) 1993-02-08 1994-08-18 Paravax, Inc. Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
ATE234855T1 (de) * 1993-09-20 2003-04-15 Anadis Ltd Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen
US5595761A (en) 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5635210A (en) * 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
KR20000010591A (ko) * 1996-04-22 2000-02-15 피터 알. 로쓰쉴드 항b형간염백신의안정화정제
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
AU4133397A (en) * 1996-10-28 1998-05-22 Pfizer Inc. Oral vaccines for young animals with an enteric coating
US6150340A (en) * 1997-02-07 2000-11-21 Smithkline Beecham Corporation RNA-dependent amidotransferase from Staphylococcus aureus
JPH1121122A (ja) * 1997-07-03 1999-01-26 Akou Kaisui Kk 水溶解性に優れた塩錠剤
DE19741114C2 (de) 1997-09-12 2002-10-24 Riemser Arzneimittel Ag Feuchtigkeitsstabile und magensaftresistente Arzneiform für Fische
CU22700A1 (es) 1997-09-29 2001-07-31 Ct Ingenieria Genetica Biotech Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso
GB9722682D0 (en) 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
GB9801870D0 (en) 1998-01-28 1998-03-25 Raby Limited Vaccine composition
US6562002B1 (en) * 1999-02-16 2003-05-13 Prismedical Corporation Single dose delivery device

Also Published As

Publication number Publication date
HUP0202537A2 (hu) 2002-11-28
LT1212045T (lt) 2016-12-12
DK1212045T3 (en) 2016-11-28
WO2001013896A1 (en) 2001-03-01
JP2003507414A (ja) 2003-02-25
PT1212045T (pt) 2016-11-22
HUP0202537A3 (en) 2004-05-28
BR0014142A (pt) 2002-07-02
CN100406004C (zh) 2008-07-30
MXPA02001891A (es) 2003-07-21
CN1379663A (zh) 2002-11-13
IL148247A0 (en) 2002-09-12
AU6793400A (en) 2001-03-19
EP1212045A1 (en) 2002-06-12
RU2277905C2 (ru) 2006-06-20
EP1212045A4 (en) 2008-02-20
BRPI0014142B8 (pt) 2021-05-25
AU779403B2 (en) 2005-01-20
TR200200477T2 (tr) 2002-06-21
IL148247A (en) 2014-01-30
ZA200201816B (en) 2003-05-28
CA2382652A1 (en) 2001-03-01
ES2605109T3 (es) 2017-03-13
JP5209160B2 (ja) 2013-06-12
US6541001B1 (en) 2003-04-01
EP1212045B1 (en) 2016-08-17
CY1118521T1 (el) 2017-07-12
BRPI0014142B1 (pt) 2016-09-27
HK1047696A1 (zh) 2003-03-07

Similar Documents

Publication Publication Date Title
IL148247A0 (en) A vaccine composition and method of using the same
EP1176948A4 (en) COMPOSITIONS AND METHODS
GB9918319D0 (en) Vaccine composition
HUP0200898A2 (en) Derivatives of venlafaxine and methods of preparing and using the same
SI1185536T1 (en) Hemisynthetic method and intermediates thereof
EP1223932A4 (en) COMPOUNDS AND METHODS
EP1146790A4 (en) COMPOUNDS AND METHODS
AP2001002300A0 (en) Hiv immunogenic compositions and methods
GB9924351D0 (en) Immunomodulation methods and compositions
GB9910812D0 (en) Vaccine composition
AU6832101A (en) Composition and method
AU4163402A (en) Composition and method
ZA200306573B (en) A vaccine composition and method of using the same
GB9819898D0 (en) New vaccine and method of use
AU2001260774A1 (en) Bio-support and preparing method of the same
EP1146136A4 (en) ORNAMENT AND METHOD FOR ITS MANUFACTURE
EG22491A (en) Rest-breaking composition and use thereof
EP1209234A4 (en) DECARABAMYLASE STEREOSTRUCTURE AND METHOD OF USE
AP2002002429A0 (en) Novel composition and emulsifier
EP1272512A4 (en) IMMUNOKIN COMPOSITION AND METHOD
GB9929493D0 (en) Composition and method
GB9917409D0 (en) Composition and method
HK1062399A (en) A vaccine composition and method of using the same
GB9919362D0 (en) Novel method and compounds
GB9905518D0 (en) Novel method and compound

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)